Abstract
Objective: To observe the levels of serum C-reactive protein (CRP), endothelin-1 (ET-1), nitric oxide (NO), and superoxide dismutase (SOD) in patients after intracoronary stenting (ICS), and the effects of Erigeron Injection (EI) on them.Methods: Seventy-two patients, who received ICS and had symptoms of chest stuffiness, palpitation and chest pain, were randomly divided into two groups, with 36 patients in the control group treated with Plavix alone for anti-platelet aggregation, and the other 36 patients in the treated group treated with Plavix and EI in combination. CRP, ET-1, NO and SOD were determined and compared before and 1, 2 and 3 weeks after treatment.Results: As compared with those in the control group, improvement of symptoms in the treated group was significantly better, with the levels of CRP and ET-1 lower and levels of SOD and NO higher or approaching to normal ranges and significant difference was shown between the two groups (P < 0.01).Conclusion: EI could alleviate uncomfortable feelings such as chest stuffiness in patients after ICS, and improve the function of vascular endothelium.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
State Administration of Traditional Chinese Medicine. Trade standard of Peoples Republic of China. 1995: 18–19.
Zhang MZ, Tian WJ, Zou X, et al. Thinking and method of TCM syndrome differentiation depending therapy before and after coronary invention treatment of acute myocardial infarction: analysis on treatment of 70 Patients. Chin J Integr Tradit West Med 2004;7(24): 638–639.
Yu AZ. Li JF, Li GS, et al. A clinical study on the minor myocardial injury associated with percutaneous coronary intervention. J Chin Phys 2004;5(5): 629–630.
Hu DY, Zhao MZ. Therapy level of coronary heart disease in our country. Chin J Pract Intern Med 2005;25 (1): 3–4.
Liu SY, Zhang H, Li YJ, et al. Protective effect and mechanism of Honghua Injection on myocardial ischemia during intervention treatment inpatients with coronary heart diseases. J Heibei Tradit Chin Med Pharmacol 2004;19(4): 29–31.
Ju Y. Significance and change of serum ET, TNF-α and NO in patients with coronary heart disease. Chin J Med Pract 2005;94(1): 122–123.
Zhang J, Li XS, Zhang WD. Progress on chemical ingredients and pharmacological activity of Chinese herbal Erigeronis. J Pharm Pract 2002;2: 156–157.
Shen L, Ji HF, Chai JG. Theoretical assessment on clearing activity of free radical by nine kinds of nature products. Acta Biophys Sin 2005;10(21): 333–335.
Zhong HJ, Deng YJ. Progress on new dosage form of Erigeronis. Chin Tradit Pat Med 2005; (8): 178–179.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Xiao-ying, W., Feng, M. Effects of Erigeron Injection on vascular endothelium in patients after intracoronary stenting. Chin. J. Integr. Med. 12, 185–188 (2006). https://doi.org/10.1007/BF02836519
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02836519